Press release
BosterBio's ACAA2 Antibody Leads the Way in Advancing Cutting-Edge Research
BosterBio's expertise in antibody production and its exceptional technical support and educational resources make it a trusted partner for researchers in academia, pharmaceuticals, and biotechnology.
Refining its techniques and technology over the last three decades, Boster Biological Technology continues to build on its reputation as a trusted partner for researchers worldwide, offering a wide range of products, including the highly sought-after ACAA2 antibody, PLAU antibody, Urokinase antibody, Plasminogen antibody, SFN antibody, Stratifin antibody, and 14-3-3 sigma antibody.
Headquartered in Pleasanton, California, BosterBio [https://www.bosterbio.com/] has become synonymous with reliability, innovation, and exceptional customer service, earning the trust of the scientific community through its unwavering commitment to quality, accuracy, and innovation. The company specializes in producing high-quality antibodies and immunoassay kits that meet the rigorous demands of modern research. Heavily investing in cutting-edge technologies, BosterBio ensures its products deliver consistent and reproducible results.
BosterBio's extensive product catalog includes a variety of antibodies critical to groundbreaking research. Among its standout offerings are the Urokinase antibody and Plasminogen antibody, which play pivotal roles in studies on cancer, thrombosis, and tissue remodeling. These antibodies are rigorously validated for applications such as Western blot, immunohistochemistry, and flow cytometry, ensuring researchers have the tools to achieve accurate and reliable results.
The company also excels in producing antibodies like the SFN antibody and Stratifin antibody that play an essential role in cell signaling, apoptosis, and cancer biology research. Similarly, BosterBio's 14-3-3 sigma antibody is widely recognized for its role in studying cell cycle regulation and stress responses. Each product is manufactured under strict quality control protocols, guaranteeing high specificity, sensitivity, and batch-to-batch consistency.
BosterBio's success is driven by its team of experienced scientists and researchers who are passionate about advancing scientific discovery. The company invests heavily in research and development to stay at the forefront of antibody production and immunoassay technologies. This commitment to innovation ensures that BosterBio remains a leader in the field, offering products that meet the evolving needs of the scientific community.
What sets BosterBio apart is its dedication to customer satisfaction, providing comprehensive technical support, detailed product documentation, and customized solutions to meet the unique needs of its clients. This customer-centric approach has made BosterBio a preferred partner for academic institutions, pharmaceutical companies, and biotech firms.
For more information, visit https://www.bosterbio.com/
With over 30 years of experience in designing high-affinity antibodies and immunoassays and with its products cited in more than 60,000 publications, Boster Bio boasts an offering of over 2,000 ELISA kits and 20,000 antibodies, of which at least 16,000 have been validated for IHC, WB, ELISA, and FC in human, mouse, and rat samples.
Complementing its antibody offerings, BosterBio provides a range of ELISA kits designed for quantitative detection of proteins, cytokines, and other biomarkers. These kits are widely used in drug development, clinical diagnostics, and basic research, further cementing BosterBio's position as a one-stop solution for life science research.
BosterBio is dedicated to providing high-quality products to foster a deeper understanding of scientific research. The company offers a wealth of educational resources, including detailed protocols, application guides, and troubleshooting tips, to help researchers maximize the potential of their experiments. This emphasis on education and accessibility underscores BosterBio's mission to empower scientists and accelerate discoveries.
As the demand for advanced research tools grows, Boster Biological Technology remains committed to delivering innovative solutions that drive scientific progress. With its focus on quality, customer support, and cutting-edge technologies, BosterBio is poised to remain a trusted partner for researchers around the globe.
About the Company:
Boster Biological Technology is a leading provider of high-quality antibodies and ELISA kits, headquartered in Pleasanton, California. Renowned for its commitment to innovation and reliability, BosterBio offers a comprehensive portfolio of research tools, including the ACAA2 antibody, PLAU antibody, Urokinase antibody, Plasminogen antibody, SFN antibody, Stratifin antibody, and 14-3-3 sigma antibody. These products are rigorously validated for applications such as Western blot, immunohistochemistry, and flow cytometry, ensuring consistent and reproducible results.
Media Contact
Company Name: Boster Biological Technology
Contact Person: CJ Xia
Email: Send Email [http://www.universalpressrelease.com/?pr=bosterbios-acaa2-antibody-leads-the-way-in-advancing-cuttingedge-research]
Phone: (888)466-3604
Address:3942 Valley Ave
City: Pleasanton
State: CA 94566
Country: United States
Website: https://www.bosterbio.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release BosterBio's ACAA2 Antibody Leads the Way in Advancing Cutting-Edge Research here
News-ID: 3913276 • Views: …
More Releases from Getnews
Federixa & BEAX release their electronic music
Image: https://www.globalnewslines.com/uploads/2025/12/5f95777dcc1e2dcc357a8a1d12fb3e49.jpg
Experimentation and creativity with over 100 official tracks at just 10 and 8 years old
Federixa (10 years old) and BEAX (8 years old) are two young Italian producers and songwriters with an overwhelming passion for electronic music. They don't sing, but they produce, write, and create original sounds ranging from Tech House to Melodic Techno, from Electro Dance to Electronic Hip Hop. Despite their young age, they are already…
brainSHARE Founder and Chamber Board Member Joe Siecinski Launches Complimentary …
Image: https://www.globalnewslines.com/uploads/2025/12/1765328151.jpg
"I can't stop the business ground from shifting. But through this program, I can help owners strengthen the systems and human connection they need to find their footing and move forward with confidence. That's why this matters now more than ever." - Joe Siecinski, Founder: brainShare Business Mentors.
brainSHARE Founder Joe Siecinski is offering new Silicon Valley Chamber members two months of free access to The Success Circle, helping business…
Otonomus Hotels Announces Global Expansion Following the Success of its Las Vega …
Las Vegas, NV - December 10, 2025 - Otonomus Hotels, recognized for launching what industry observers have called the world's first fully AI-powered hotel, is entering a significant global expansion phase following a strong debut in Las Vegas. The company has announced plans to open 40 new locations worldwide, bringing its technology-driven hospitality model to major destinations across the United States, Europe, Asia, and the Middle East.
Image: https://www.globalnewslines.com/uploads/2025/12/85650c1609eb28f4abc4997702a8d505.jpg
Launched early this…
Healing Through Exile: How Distance Becomes the Road Home Again
Image: https://www.globalnewslines.com/uploads/2025/12/1765400936.jpg
In its final movement, From Error to Error, Back and Forth transcends the confines of memoir and enters the realm of philosophical literature. Monika Killeen's M - now settled on a small island off the coast of New Zealand - reflects on freedom, belonging, and the fragile equilibrium of happiness.
Through encounters with new friends like the enigmatic Constance, and moments of startling clarity, M begins to understand that peace…
More Releases for Boster
Boster Bio Supports Researchers with Free Antibody Validation, Elevating IHC Ser …
Image: https://www.globalnewslines.com/uploads/2025/10/1759715944.jpg
With complementary validation services and the expansion of its IHC service lab, Boster Bio goes beyond being a product supplier, reinforcing its role as a partner in research.
Boster Biological Technology (Boster Bio), a supplier of high-quality antibodies and immunoassays for over 30 years and a recipient of CiteAb recognition for antibody quality, announced a free antibody validation program alongside enhancements to its Immunohistochemistry (IHC) service lab, giving researchers end-to-end…
Cutting-Edge Antibody Validation Service by Boster Bio Set to Enhance Research A …
Image: https://www.globalnewslines.com/uploads/2025/09/1757383340.jpg
Boster Bio advances biomedical research with rigorously validated antibodies and expert IHC services, ensuring reproducibility for scientists worldwide.
Boster Biological Technology (Boster Bio), a leading provider of antibody and immunoassay solutions, is revolutionizing biomedical research with its antibody validation service [https://www.bosterbio.com/promotions/free-validation-for-picoband-antibodies] and IHC services [https://www.bosterbio.com/services/assay-services/ihc-histology-services]. These offerings ensure researchers receive rigorously tested, high-quality reagents, addressing a critical need for reproducibility in scientific studies.
A major challenge in life sciences research…
Boster Bio Launches Free Antibody Validation Service to Transform Research Repro …
Image: https://www.globalnewslines.com/uploads/2025/06/1750910150.jpg
In a bold move that could reshape the future of biomedical research, Boster Bio is launching a Free Antibody Validation Program [https://www.bosterbio.com/promotions/free-validation-for-picoband-antibodies]-giving scientists the power to test antibodies under their exact experimental conditions before purchase. It's a first-of-its-kind, no-cost service that tackles one of science's most frustrating pain points: unreliable antibodies.
"For too long, researchers have had to gamble on antibodies that may or may not work," said CJ Xia,…
Free Antibody Validation: Boster Bio Launches New Service to Advance Research Re …
Image: https://www.globalnewslines.com/uploads/2025/05/1748483446.jpg
With Boster Bio's latest promotion, scientists globally enjoy free access to antibody validation to boost research accuracy.
Boster Biological Technology, a leading provider of high-quality antibodies and ELISA kits, has announced a new promotion offering free antibody validation [https://www.bosterbio.com/promotions/free-validation-for-picoband-antibodies] for its PicoBand antibody line. This initiative is designed to help scientists worldwide enhance research reliability by eliminating guesswork in antibody selection, allowing researchers to verify antibody specificity before purchase.
The…
Periostin Antibody: Boster Biological Technology Pioneers Breakthrough Antibodie …
Image: https://www.globalnewslines.com/uploads/2025/04/1745389004.jpg
Boster Bio Technology unlocks insights into cancer and neurological disorders with high-quality antibodies that offer exceptional specificity and sensitivity.
Boster Biological Technology, a leading antibody and immunoassay provider based in Pleasanton, California, has established itself as a trusted partner for researchers worldwide. Specializing in antibodies such as the periostin antibody [https://www.bosterbio.com/anti-periostin-antibody-pa2048-boster.html], ALDH7A1 antibody [https://www.bosterbio.com/anti-aldh7a1-antibody-a03712-boster.html], and ANAPC2 antibody [https://www.bosterbio.com/anti-apc2-antibody-a06153-boster.html], BosterBio serves academic institutions, pharmaceutical companies, and biotech firms.
Since its founding,…
Global Carcinoembryonic Antigen Market 2020 Business Strategies – Boster Biolo …
The research report titled “Carcinoembryonic Antigen Market: by Application (Thyroid Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Gastrointestinal Cancer and Other Applications); by End User (Research and Academic Institutes, Diagnostic Centers, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025” and published by “Zion Market Research” is an in-depth and dedicated scrutiny of the existing stats of the global Carcinoembryonic Antigen market…
